Cerebral Dynamic Perfusion Study With Spectral CT in Patients Suspected of Stroke
NCT ID: NCT03948425
Last Updated: 2020-11-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
28 participants
INTERVENTIONAL
2017-06-08
2019-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Correlate the anomalies of iodine mapping to the other parameters acquired during the classic dynamic infusion phase to define the ischemic area (MTT higher and rCBV normal) versus infarcted zone (MTT higher and rCBV decreased)
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Stroke
Clinical suspicion of hyperacute stroke (6 hours after onset of symptoms):Intervention 'spectral CT'
spectral CT
Head spectral CT
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
spectral CT
Head spectral CT
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age between 50 and 95 years
* Weight: between 65 and 95 kg
Exclusion Criteria
* Renal impairment with creatinine clearance \<60 ml / min
* Hemorrhagic lesions or vascular abnormalities demonstrated on CT before contrast injection
50 Years
95 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Emmanuel Coche, MD-PhD
Role: PRINCIPAL_INVESTIGATOR
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cliniques universitaires saint Luc
Brussels, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Duprez T, Vlassenbroek A, Peeters A, Poncelet PA, Levecque E, Austein F, Pahn G, Nae Y, Abdallah S, Coche E. Preliminary experience of CT imaging of the ischaemic brain penumbra through spectral processing of multiphasic CTA datasets. Sci Rep. 2023 Jul 15;13(1):11431. doi: 10.1038/s41598-023-38370-9.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017/12AVR/209
Identifier Type: OTHER
Identifier Source: secondary_id
AVC AIGUS
Identifier Type: -
Identifier Source: org_study_id